SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Sun Rui)
 

Search: WFRF:(Sun Rui) > (2015-2019) > Prostate Specific A...

Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts

Chen, Rui (author)
Second Military Medical University
Sjoberg, Daniel D. (author)
Memorial Sloan-Kettering Cancer Center
Huang, Yiran (author)
Shanghai Jiao Tong University
show more...
Xie, Liping (author)
Zhejiang University
Zhou, Liqun (author)
Peking University First Hospital
He, Dalin (author)
Xi'an Jiaotong University
Vickers, Andrew J. (author)
Memorial Sloan-Kettering Cancer Center
Sun, Yinghao (author)
Second Military Medical University
Sun, Yinghao (creator_code:cre_t)
Lilja, Hans (creator_code:cre_t)
Lund University,Lunds universitet,Klinisk kemi, Malmö,Forskargrupper vid Lunds universitet,Clinical Chemistry, Malmö,Lund University Research Groups
show less...
 (creator_code:org_t)
 
show more...
 
show less...
Ovid Technologies (Wolters Kluwer Health), 2017
2017
English 7 s.
In: Journal of Urology. - : Ovid Technologies (Wolters Kluwer Health). - 0022-5347 .- 1527-3792. ; 197:1, s. 90-96
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Purpose We determined the characteristics of Chinese men undergoing initial prostate biopsy and evaluated the relationship between prostate specific antigen levels and prostate cancer/high grade prostate cancer detection in a large Chinese multicenter cohort. Materials and Methods This retrospective study included 13,904 urology outpatients who had undergone biopsy for the indications of prostate specific antigen greater than 4.0 ng/ml or prostate specific antigen less than 4.0 ng/ml but with abnormal digital rectal examination results. The prostate specific antigen measurements were performed in accordance with the standard procedures at the respective institutions. The type of assay used was documented and recalibrated to the WHO standard. Results The incidence of prostate cancer and high grade prostate cancer was lower in the Chinese cohort than the Western cohorts at any given prostate specific antigen level. Around 25% of patients with a prostate specific antigen of 4.0 to 10.0 ng/ml were found to have prostate cancer compared to approximately 40% in U.S. clinical practice. Moreover, the risk curves were generally flatter than those of the Western cohorts, that is risk did not increase as rapidly with higher prostate specific antigen. Conclusions The relationship between prostate specific antigen and prostate cancer risk differs importantly between Chinese and Western populations, with an overall lower risk in the Chinese cohort. Further research should explore whether environmental or genetic differences explain these findings or whether they result from unmeasured differences in screening or benign prostate disease. Caution is required for the implementation of prostate cancer clinical decision rules or prediction models for men in China or other Asian countries with similar genetic and environmental backgrounds.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

biopsy
China
early detection of cancer
prostate-specific antigen
prostatic neoplasms

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view